Login / Signup

Improvement in sinonasal quality-of-life indicators for pediatric patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.

Carlos X CastellanosBeth OsterbauerSteven HasdayThomas G KeensJeffrey KoempelElisabeth H Ference
Published in: International forum of allergy & rhinology (2022)
Keyphrases
  • cystic fibrosis
  • newly diagnosed